Prognostic factors for resected non-small cell lung cancer with pN2 status: Implications for use of postoperative radiotherapy

Oncologist

Volumn 14, Issue 11, 2009, Pages 1106-1115

  Moretti, Luigi ^a   Yu, David S ^a   Chen, Heidi ^a   Carbone, David P ^a   Johnson, David H ^a   Keedy, Vicki L ^a   Putnam Jr , Joe B ^a   Sandler, Alan B ^a   Shyr, Yu ^a   Lu, Bo ^a  

^a VANDERBILT INGRAM CANCER CENTER   (United States)

Author keywords

Adjuvant radiotherapy; Extracapsular extension; Non small cell lung cancer; pN2; Prognostic factors

Indexed keywords

CARBOPLATIN; CISPLATIN; NAVELBINE; PACLITAXEL;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER INVASION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; COMPUTER ASSISTED TOMOGRAPHY; CONTINUING EDUCATION; DISEASE FREE SURVIVAL; DISTANT RECURRENCE FREE SURVIVAL; EXTRACAPSULAR EXTENSION; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; KAPLAN MEIER METHOD; LUNG CANCER; LUNG NON SMALL CELL CANCER; LUNG RESECTION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OVERALL SURVIVAL; POSTOPERATIVE CARE; POSTOPERATIVE RADIOTHERAPY; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RECURRENCE FREE SURVIVAL; RETROSPECTIVE STUDY; SURVIVAL RATE; TREATMENT OUTCOME; TUMOR VOLUME; UNIVARIATE ANALYSIS;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PNEUMONECTOMY; POSTOPERATIVE CARE; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 75449108663     PISSN: 10837159     EISSN: 1549490X     Source Type: Journal    
DOI: 10.1634/theoncologist.2009-0130     Document Type: Article

References (36)

1. Jemal A, Siegel R, Ward E et al. Cancer statistics, 2007. CA Cancer J Clin 2007;57:43-66.
2. Arriagada R, Bergman B, Dunant A et al. Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer. N Engl J Med 2004;350:351-360.
3. Douillard JY, Rosell R, De LenaMet al. Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): A randomised controlled trial. Lancet Oncol 2006;7: 719-727.
4. Dautzenberg B, Arriagada R, Chammard AB et al. A controlled study of postoperative radiotherapy for patients with completely resected nonsmall cell lung carcinoma. Groupe d'Etude et de Traitement des Cancers Bronchiques. Cancer 1999;86:265-273.
5. Kelsey CR, Light KL, Marks LB. Patterns of failure after resection of non-small-cell lung cancer: Implications for postoperative radiation therapy volumes. Int J Radiat Oncol Biol Phys 2006;65:1097-1105.
6. Rosell R, Gómez-Codina J, Camps C et al. A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small-cell lung cancer. N Engl J Med 1994;330:153-158.
7. Erman M, Moretti L, Soria JC et al. Adjuvant chemotherapy and radiotherapy in non-small cell lung cancer. Semin Radiat Oncol 2004;14:315-321.
8. Effects of postoperative mediastinal radiation on completely resected stage II and stage III epidermoid cancer of the lung. The Lung Cancer Study Group. N Engl J Med 1986;315:1377-1381.
9. Feng QF, Wang M, Wang LJ et al. A study of postoperative radiotherapy in patients with non-small-cell lung cancer: A randomized trial. Int J Radiat Oncol Biol Phys 2000;47:925-929.
10. Mayer R, Smolle-Juettner FM, SzolarDet al. Postoperative radiotherapy in radically resected non-small cell lung cancer. Chest 1997;112:954-959.
11. Stephens RJ, Girling DJ, Bleehen NM et al. The role of post-operative radiotherapy in non-small-cell lung cancer: A multicentre randomised trial in patients with pathologically staged T1-2, N1-2, M0 disease Medical Research Council Lung Cancer Working Party. Br J Cancer 1996;74:632-639.
12. PORT Meta-Analysis Trialists Group. Postoperative radiotherapy in non-small-cell lung cancer: Systematic review and meta-analysis of individual patient data from nine randomised controlled trials. Lancet 1998;352:257-263.
13. Munro AJ. What now for postoperative radiotherapy for lung cancer? Lancet 1998;352:250-251.
14. Bekelman JE, Rosenzweig KE, Bach PB et al. Trends in the use of postoperative radiotherapy for resected non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2006;66:492-499.
15. Lally BE, Zelterman D, Colasanto JM et al. Postoperative radiotherapy for stage II or III non-small-cell lung cancer using the Surveillance, Epidemiology, and End Results database. J Clin Oncol 2006;24:2998-3006.
16. Douillard JY, Rosell R, De LenaMet al. Impact of postoperative radiation therapy on survival in patients with complete resection and stage I, II, or IIIA non-small-cell lung cancer treated with adjuvant chemotherapy: The adjuvant Navelbine International Trialist Association (ANITA) randomized trial. Int J Radiat Oncol Biol Phys 2008;72:695-701.
17. Ravdin PM, Davis G. Prognosis of patients with resected non-small cell lung cancer: Impact of clinical and pathologic variables. Lung Cancer 2006;52:207-212.
18. Andre F, Grunenwald D, Pignon JP et al. Survival of patients with resected N2 non-small-cell lung cancer: Evidence for a subclassification and implications. J Clin Oncol 2000;18:2981-2989.
19. Miller DL, McManus KG, Allen MS et al. Results of surgical resection in patients with N2 non-small cell lung cancer. Ann Thorac Surg 1994;57: 1095-1100, discussion 1100-1101.
20. Mountain CF. Surgery for stage IIIa-N2 non-small cell lung cancer. Cancer 1994;73:2589-2598.
21. Sawyer TE, Bonner JA, Gould PM et al. The impact of surgical adjuvant thoracic radiation therapy for patients with nonsmall cell lung carcinoma with ipsilateral mediastinal lymph node involvement. Cancer 1997;80: 1399-1408.
22. Ishida T, Tateishi M, Kaneko S et al. Surgical treatment of patients with nonsmall-cell lung cancer and mediastinal lymph node involvement. J Surg Oncol 1990;43:161-166.
23. Roeslin N, Warter A, Gasser B et al. [Non-aplastic N2 operated bronchial cancers. Multifactorial analysis of the prognosis.] Ann Chir 1991;45:673-678. In French.
24. van Klaveren RJ, Festen J, Otten HJ et al. Prognosis of unsuspected but completely resectable N2 non-small cell lung cancer. Ann Thorac Surg 1993;56:300-304.
25. Vansteenkiste JF, De Leyn PR, Deneffe GJ et al. Survival and prognostic factors in resected N2 non-small cell lung cancer: A study of 140 cases. Leuven Lung Cancer Group. Ann Thorac Surg 1997;63:1441-1450.
26. Martini N, Flehinger BJ. The role of surgery in N2 lung cancer. Surg Clin North Am 1987;67:1037-1049.
27. Régnard JF, Magdeleinat P, Azoulay D et al. Results of resection for bronchogenic carcinoma with mediastinal lymph node metastases in selected patients. Eur J Cardiothorac Surg 1991;5:583-586; discussion 587.
28. Goldstraw P, Mannam GC, Kaplan DK et al. Surgical management of non-small-cell lung cancer with ipsilateral mediastinal node metastasis (N2 disease). J Thorac Cardiovasc Surg 1994;107:19-27; discussion 27-28.
29. Ragaz J, Jackson SM, Le N et al. Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N Engl J Med 1997;337:956-962.
30. Matsuguma H, Nakahara R, Ishikawa Y et al. Postoperative radiotherapy for patients with completely resected pathological stage IIIA-N2 non-small cell lung cancer: Focusing on an effect of the number of mediastinal lymph node stations involved. Interact Cardiovasc Thorac Surg 2008;7:573-577.
31. Huang DT, Johnson CR, Schmidt-Ullrich R et al. Postoperative radiotherapy in head and neck carcinoma with extracapsular lymph node extension and/or positive resection margins: A comparative study. Int J Radiat Oncol Biol Phys 1992;23:737-742.
32. Huang EH, Tucker SL, Strom EA et al. Predictors of locoregional recurrence in patients with locally advanced breast cancer treated with neoadjuvant chemotherapy, mastectomy, and radiotherapy. Int J Radiat Oncol Biol Phys 2005;62:351-357.
33. Neri A, Marrelli D, Roviello F et al. Prognostic value of extracapsular extension of axillary lymph node metastases in T1 to T3 breast cancer. Ann Surg Oncol 2005;12:246-253.
34. Heide J, Krull A, Berger J. Extracapsular spread of nodal metastasis as a prognostic factor in rectal cancer. Int J Radiat Oncol Biol Phys 2004;58: 773-778.
35. Lee YC, Wu CT, Kuo SW et al. Significance of extranodal extension of regional lymph nodes in surgically resected non-small cell lung cancer. Chest 2007;131:993-999.
36. Winton T, Livingston R, Johnson D et al. Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer. N Engl J Med 2005;352: 2589-2597.